Crossmark

Alzheimer disease and aducanumab: adjusting our approach

Crossref DOI link: https://doi.org/10.1038/s41582-019-0205-1

Published Online: 2019-05-28

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Selkoe, Dennis J. https://orcid.org/0000-0001-8846-9767
License Information

Text and Data Mining valid from 2019-05-28

Version of Record valid from 2019-05-28
More Information

Article History

First Online: 28 May 2019

Competing interests

: D.J.S. is a consultant for E-Scape Bio and Prothena.